Teva Pharmaceuticals
TEVA
TEVA
821 hedge funds and large institutions have $32.5B invested in Teva Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 78 funds opening new positions, 281 increasing their positions, 297 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
0% more funds holding
Funds holding: 821 → 821 (0)
0.28% less ownership
Funds ownership: 54.89% → 54.6% (-0.28%)
5% less repeat investments, than reductions
Existing positions increased: 281 | Existing positions reduced: 297
Holders
821
Holding in Top 10
70
Calls
$780M
Puts
$412M
Top Buyers
| 1 | +$563M | |
| 2 | +$265M | |
| 3 | +$230M | |
| 4 |
PC
PointState Capital
New York
|
+$138M |
| 5 |
First Eagle Investment Management
New York
|
+$109M |
Top Sellers
| 1 | -$969M | |
| 2 | -$916M | |
| 3 | -$394M | |
| 4 |
CG
Carmignac Gestion
Paris,
France
|
-$352M |
| 5 |
SFM
Soros Fund Management
New York
|
-$279M |